Generics Development

Generic drugs play a pivotal role in the pharmaceutical industry, making up more than 80% of all prescriptions. They are equivalent to approved brand-name drugs, but cost around 85% less, making them an affordable choice for patients. Despite constituting over 90% of all prescribed medications, generics only represent less than 20% of total pharmaceutical spending in the U.S.

We extend an invitation to both emerging pharmaceutical firms requiring assistance in accelerating their product’s market arrival, and investors keen on breaking into the pharmaceutical industry but lacking the technical and scientific knowledge to develop a product in a time-efficient manner. Our focus is on providing flexible, science-driven, comprehensive services at every phase of your drug development process.

Our scientific teams have a wealth of experience in early-stage formulation development of both straightforward and intricate formulations.

Investors who are interested in making their mark in the healthcare industry and sponsoring the development and commercialization of a generic drug are welcome to get in touch. We have a portfolio of over 200 generic drugs ready for sponsorship, with several already in development. Within just two weeks from the initial consultation, we will provide you with a detailed report and a consultation meeting to map out a proposed and expedited pathway for your product development.

Our commitment lies in delivering excellence. We harness our unique scientific methodologies to develop complex oral solids and alternative dosage forms, concentrating on high-value, challenging, first-to-file or first-to-market product opportunities. Our development capabilities are second to none and cover all dosage forms, including complex oral solids, liquids, topicals, and transdermals.

We work on products across a wide range of therapeutic areas such as cardiovascular, central nervous system/pain, oncology, inflammation, anti-infective, dermatology, endocrinology, diabetes, rhinology, urology, and hematology, among others.

Our dedicated, highly skilled team of scientists focuses on developing various dosage forms. This includes Immediate Release (IR)/ Extended Release (ER) products, powder for suspension, solutions, suspensions, topical dosage forms like creams, ointments, lotions, solutions, and the development of other formulations.

To learn more on how Synergy Bioscience can support your organization, please contact us